Home/Pipeline/Clinical Trial Support for Pharma

Clinical Trial Support for Pharma

Central Nervous System Disorders

N/A (Platform)Active

Key Facts

Indication

Central Nervous System Disorders

Phase

N/A (Platform)

Status

Active

Company

Cognision

About Cognision

Cognision operates at the intersection of neuroscience and digital health, providing a unified platform called Cognision360™ for electronic-sourced digital biomarkers in central nervous system (CNS) clinical trials and research. The company leverages quantitative EEG (qEEG), Event-Related Potentials (ERP), polysomnography, eye-tracking, and wearable sensor data to deliver objective measures of cognitive and cortical function. Its technology is positioned to address the need for sensitive, reliable, and scalable tools in drug development for neurological disorders and cognitive research. As a private company, it appears to be in an early-revenue or pre-revenue stage, serving biopharma clients and research institutions.

View full company profile

Therapeutic Areas

Neuroscience Cognitive Disorders Dementia Concussion/mTBI Sleep Disorders

Other Central Nervous System Disorders Drugs

Drug	Company	Phase	Status
CNS Pipeline Candidates	Aucta Pharmaceuticals	Not Specified	Active R&D
Neurodegenerative/CNS Discovery	Adamed	Research/Pre-clinical	Active
Undisclosed CNS Program(s)	Biomia	Preclinical	Active